This blog explores how AI-powered systems biology is transforming drug development from traditional methods into a data-driven, personalized, and predictive process. With a focus on genomics, metabolomics, and patient-specific modeling, it highlights how Trustlife is leading this transformation. Learn how AI-assisted molecule modeling, scenario simulations, and precision-driven trial strategies are shaping the future of pharmaceutical innovation.
